Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 1,000 shares at $11.20 ($11K) on 2007-03-01, disclosed to the SEC on 2007-03-02.
Scheduled sale ($11k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.09 | 100 | $1K | 9.9% |
| 2 | $11.11 | 100 | $1K | 9.9% |
| 3 | $11.14 | 100 | $1K | 9.9% |
| 4 | $11.17 | 100 | $1K | 10.0% |
| 5 | $11.20 | 300 | $3K | 30.0% |
| 6 | $11.25 | 200 |
| $2K |
| 20.1% |
| 7 | $11.42 | 100 | $1K | 10.2% |
| Total | $11.20 avg | 1,000 | $11K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |